Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: OSTEOPROTEGERIN, . Treffer: 20

2021

Wallentin, L; Eriksson, N; Olszowka, M; Grammer, TB; Hagström, E; Held, C; Kleber, ME; Koenig, W; März, W; Stewart, RAH; White, HD; Åberg, M; Siegbahn, A Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study.
PLOS MED. 2021; 18(1): e1003513-e1003513. Doi: 10.1371/journal.pmed.1003513 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2020

Ewert, A; Leifheit-Nestler, M; Hohenfellner, K; Büscher, A; Kemper, MJ; Oh, J; Billing, H; Thumfart, J; Stangl, G; Baur, AC; Föller, M; Feger, M; Weber, LT; Acham-Roschitz, B; Arbeiter, K; Tönshoff, B; Zivicnjak, M; Haffner, D Bone and Mineral Metabolism in Children with Nephropathic Cystinosis Compared with other CKD Entities.
J Clin Endocrinol Metab. 2020; 105(8): Doi: 10.1210/clinem/dgaa267
Web of Science PubMed FullText FullText_MUG

 

2018

Awaja, F; Speranza, G; Kaltenegger, H; Coraça-Huber, D; Lohberger, B Surface modification and characterization of GO/polymer thin coatings as excellent bio-active platforms for tissue regeneration.
Mater Sci Eng C Mater Biol Appl. 2018; 84: 130-139. Doi: 10.1016/j.msec.2017.11.030
Web of Science PubMed FullText FullText_MUG

 

Sanz, M; Ceriello, A; Buysschaert, M; Chapple, I; Demmer, RT; Graziani, F; Herrera, D; Jepsen, S; Lione, L; Madianos, P; Mathur, M; Montanya, E; Shapira, L; Tonetti, M; Vegh, D Scientific evidence on the links between periodontal diseases and diabetes: Consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International diabetes Federation and the European Federation of Periodontology.
Diabetes Res Clin Pract. 2018; 137:231-241 Doi: 10.1016/j.diabres.2017.12.001
Web of Science PubMed FullText FullText_MUG

 

Sanz, M; Ceriello, A; Buysschaert, M; Chapple, I; Demmer, RT; Graziani, F; Herrera, D; Jepsen, S; Lione, L; Madianos, P; Mathur, M; Montanya, E; Shapira, L; Tonetti, M; Vegh, D Scientific evidence on the links between periodontal diseases and diabetes: Consensus report and guidelines of the joint workshop on periodontal diseases and diabetes by the International Diabetes Federation and the European Federation of Periodontology.
J Clin Periodontol. 2018; 45(2):138-149 Doi: 10.1111/jcpe.12808
Web of Science PubMed FullText FullText_MUG

 

2016

Schweighofer, N; Aigelsreiter, A; Trummer, O; Graf-Rechberger, M; Hacker, N; Kniepeiss, D; Wagner, D; Stiegler, P; Trummer, C; Pieber, T; Obermayer-Pietsch, B; Müller, H Direct comparison of regulators of calcification between bone and vessels in humans.
Bone. 2016; 88:31-38 Doi: 10.1016/j.bone.2016.04.016
Web of Science PubMed FullText FullText_MUG

 

2015

Nemeth, ZK; Mardare, NG; Czira, ME; Deak, G; Kiss, I; Mathe, Z; Remport, A; Ujszaszi, A; Covic, A; Molnar, MZ; Mucsi, I Serum osteoprotegerin is associated with pulse pressure in kidney transplant recipients.
Sci Rep. 2015; 5(1):14518-14518 Doi: 10.1038/srep14518 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2014

Todenhöfer, T; Hennenlotter, J; Leidenberger, P; Wald, A; Hohneder, A; Kühs, U; Mischinger, J; Aufderklamm, S; Gakis, G; Blumenstock, G; Stenzl, A; Schwentner, C Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy.
BJU Int. 2014; 113(1):152-159 Doi: 10.1111/j.1464-410X.2012.11759.x
Web of Science PubMed FullText FullText_MUG

 

2012

Svensson, M; Dahle, DO; Mjen, G; Weihrauch, G; Scharnagl, H; Dobnig, H; März, W; Jardine, A; Fellström, B; Holdaas, H Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study.
Nephrol Dial Transplant. 2012; 27(6):2571-2575 Doi: 10.1093/ndt/gfr694 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Malliga, DE; Wagner, D; Fahrleitner-Pammer, A The role of osteoprotegerin (OPG) receptor activator for nuclear factor kappaB ligand (RANKL) in cardiovascular pathology - a review.
Wien Med Wochenschr. 2011; 161(23-24):565-570 Doi: 10.1007/s10354-011-0022-7
PubMed FullText FullText_MUG

 

2009

Fahrleitner-Pammer, A; Piswanger-Soelkner, JC; Pieber, TR; Obermayer-Pietsch, BM; Pilz, S; Dimai, HP; Prenner, G; Tscheliessnigg, KH; Hauge, E; Portugaller, RH; Dobnig, H Ibandronate prevents bone loss and reduces vertebral fracture risk in male cardiac transplant patients: a randomized double-blind, placebo-controlled trial.
J Bone Miner Res. 2009; 24(7): 1335-1344. Doi: 10.1359/jbmr.090216 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2008

Fahrleitner-Pammer, A; Herberth, J; Browning, SR; Obermayer-Pietsch, B; Wirnsberger, G; Holzer, H; Dobnig, H; Malluche, HH Bone Markers Predict Cardiovascular Events in Chronic Kidney Disease
J BONE MINER RES. 2008; 23(11): 1850-1858. Doi: 10.1359/jbmr.080610 [Poster] [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2007

Dobnig, H; Piswanger-Sölkner, JC; Obermayer-Pietsch, B; Tiran, A; Strele, A; Maier, E; Maritschnegg, P; Riedmüller, G; Brueck, C; Fahrleitner-Pammer, A Hip and nonvertebral fracture prediction in nursing home patients: role of bone ultrasound and bone marker measurements.
J Clin Endocrinol Metab. 2007; 92(5): 1678-1686. Doi: 10.1210/jc.2006-2079 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Hofbauer, LC; Brueck, CC; Shanahan, CM; Schoppet, M; Dobnig, H Vascular calcification and osteoporosis--from clinical observation towards molecular understanding.
Osteoporos Int. 2007; 18(3): 251-259. Doi: 10.1007/s00198-006-0282-z
Web of Science PubMed FullText FullText_MUG

 

2006

Dobnig, H; Hofbauer, LC; Viereck, V; Obermayer-Pietsch, B; Fahrleitner-Pammer, A Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients.
Osteoporos Int. 2006; 17(5):693-703 Doi: 10.1007/s00198-005-0035-4
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2005

Herrmann, M; Kraenzlin, M; Pape, G; Sand-Hill, M; Herrmann, W Relation between homocysteine and biochemical bone turnover markers and bone mineral density in peri- and post-menopausal women.
Clin Chem Lab Med. 2005; 43(10):1118-1123 Doi: 10.1515/CCLM.2005.195
Web of Science PubMed FullText FullText_MUG

 

2004

Herrmann, M; Herrmann, W The assessment of bone metabolism in female elite endurance athletes by biochemical bone markers.
Clin Chem Lab Med. 2004; 42(12):1384-1389 Doi: 10.1515/CCLM.2004.258
Web of Science PubMed FullText FullText_MUG

 

2003

Fahrleitner, A; Prenner, G; Leb, G; Tscheliessnigg, KH; Piswanger-Sölkner, C; Obermayer-Pietsch, B; Portugaller, HR; Berghold, A; Dobnig, H Serum osteoprotegerin is a major determinant of bone density development and prevalent vertebral fracture status following cardiac transplantation.
Bone. 2003; 32(1):96-106 Doi: 10.1016%2FS8756-3282%2802%2900926-2
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Fahrleitner-Pammer, A; Dobnig, H; Piswanger-Soelkner, C; Bonelli, C; Dimai, HP; Leb, G; Obermayer-Pietsch, B Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status.
Wien Klin Wochenschr. 2003; 115(9):291-297 Doi: 10.1007/BF03040334
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2002

Fahrleitner, A; Prenner, G; Kniepeiss, D; Iberer, F; Tscheliessnigg, KH; Piswanger-Sölkner, C; Obermayer-Pietsch, B; Leb, G; Dobnig, H Serum osteoprotegerin levels in patients after liver transplantation and correlation to bone turnover, bone mineral density and fracture status.
Wien Klin Wochenschr. 2002; 114(15-16):717-724
Web of Science PubMed Google Scholar

 

© Med Uni Graz Impressum